Bologna M - Search Results

1

Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators.

Angelucci A, Festuccia C, D'Andrea G, Teti A, Bologna M. Angelucci A, et al. Among authors: bologna m. Biol Chem. 2002 Jan;383(1):229-34. doi: 10.1515/BC.2002.024. Biol Chem. 2002. PMID: 11928818

2

Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement.

Festuccia C, Angelucci A, Gravina G, Eleuterio E, Vicentini C, Bologna M. Festuccia C, et al. Among authors: bologna m. Exp Cell Res. 2002 Oct 15;280(1):1-11. doi: 10.1006/excr.2002.5609. Exp Cell Res. 2002. PMID: 12372334

3

Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells.

Angelucci A, Festuccia C, Gravina GL, Muzi P, Bonghi L, Vicentini C, Bologna M. Angelucci A, et al. Among authors: bologna m. Prostate. 2004 May 1;59(2):157-66. doi: 10.1002/pros.20008. Prostate. 2004. PMID: 15042616

4

Evaluation of metastatic potential in prostate carcinoma: an in vivo model.

Angelucci A, Gravina GL, Rucci N, Festuccia C, Muzi P, Vicentini C, Teti A, Bologna M. Angelucci A, et al. Among authors: bologna m. Int J Oncol. 2004 Dec;25(6):1713-20. Int J Oncol. 2004. PMID: 15547709

5

Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.

Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, Vicentini C, Bologna M. Festuccia C, et al. Among authors: bologna m. Thromb Haemost. 2005 May;93(5):964-75. doi: 10.1160/TH04-09-0637. Thromb Haemost. 2005. PMID: 15886816

6

Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells.

Millimaggi D, Festuccia C, Angelucci A, D'Ascenzo S, Rucci N, Flati S, Bologna M, Teti A, Pavan A, Dolo V. Millimaggi D, et al. Among authors: bologna m. Int J Oncol. 2006 Apr;28(4):909-14. Int J Oncol. 2006. PMID: 16525640

7

Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.

Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, Bologna M. Festuccia C, et al. Among authors: bologna m. Clin Exp Metastasis. 1998 Aug;16(6):513-28. doi: 10.1023/a:1006590217724. Clin Exp Metastasis. 1998. PMID: 9872599

8

Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion.

Festuccia C, Giunciuglio D, Guerra F, Villanova I, Angelucci A, Manduca P, Teti A, Albini A, Bologna M. Festuccia C, et al. Among authors: bologna m. Oncol Res. 1999;11(1):17-31. Oncol Res. 1999. PMID: 10451028

9

Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.

Festuccia C, Angelucci A, Gravina GL, Villanova I, Teti A, Albini A, Bologna M. Festuccia C, et al. Among authors: bologna m. Int J Cancer. 2000 Feb 1;85(3):407-15. Int J Cancer. 2000. PMID: 10652434

10

Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines.

Angelucci A, D'Ascenzo S, Festuccia C, Gravina GL, Bologna M, Dolo V, Pavan A. Angelucci A, et al. Among authors: bologna m. Clin Exp Metastasis. 2000;18(2):163-70. doi: 10.1023/a:1006778000173. Clin Exp Metastasis. 2000. PMID: 11235992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

396 results

Search Page

Filters